| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/10/2013 | CN102070717B Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition |
| 04/10/2013 | CN102060908B Novel synthetic antithrombotic polypeptide, and preparation method and application thereof |
| 04/10/2013 | CN102058878B Prosoma pellet tablet for generating allicin in stomach and preparation method thereof |
| 04/10/2013 | CN102028936B Method for preparing oral protein medicament |
| 04/10/2013 | CN102010425B 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/10/2013 | CN101899443B Method for regulating and controlling FAF1 (Fas-associated Factor-1) genes, composition and application thereof |
| 04/10/2013 | CN101693103B Improvement of completeness of intestinal barrier |
| 04/10/2013 | CN101448951B Fusion proteins, uses thereof and processes for producing same |
| 04/10/2013 | CN101415730B Compositions and methods of use for antibodies of c-Met |
| 04/10/2013 | CN101318013B Uses of IL-4 in preparing medicament composition for treating chronic hepatic fibrosis |
| 04/10/2013 | CN101262879B Airway administration of activated protein C in inflammatory conditions affecting the respiratory tract |
| 04/10/2013 | CN101109012B Representation of vampire plasmin activator alpha 2 in yeast and manufacturing method thereof |
| 04/10/2013 | CN101098675B Stabilized calcium phosphate complexes |
| 04/10/2013 | CN101090977B Tripeptide and tetrapeptide thioethers |
| 04/10/2013 | CN101084008B Therapeutic formulations of keratinocyte growth factor |
| 04/09/2013 | US8415458 Modified vitamin K-dependent polypeptides |
| 04/09/2013 | US8415457 Modified vitamin K-dependent polypeptides |
| 04/09/2013 | US8415456 Substituted IL-15 polypeptides |
| 04/09/2013 | US8415455 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 04/09/2013 | US8415453 polynucleotides, polypeptides and antibodies for use in medical diagnosis and therapy; polypeptides coupled to liposomes containing the anticarcinogenic agents, having improved efficiency and reduced side effects |
| 04/09/2013 | US8415343 Autoimmune diseases; antiinflammatory agents; antiproliferative agents; benzodiazepine compound |
| 04/09/2013 | US8415329 Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
| 04/09/2013 | US8415325 Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels |
| 04/09/2013 | US8415320 Delivery of dsRNA to arthropods |
| 04/09/2013 | US8415318 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/09/2013 | US8415307 Antibiotic compositions for the treatment of gram negative infections |
| 04/09/2013 | US8415306 Insulin-like growth factor 1 receptor binding peptides |
| 04/09/2013 | US8415305 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 04/09/2013 | US8415304 Sparc and methods of use thereof |
| 04/09/2013 | US8415303 Method of treatment using a soluble human delta protein fragment |
| 04/09/2013 | US8415302 Surgical applications for BMP binding protein |
| 04/09/2013 | US8415301 Method of treating dyspnea associated with acute heart failure by administering H2 relaxin |
| 04/09/2013 | US8415300 Sustained release of microcrystalline peptide suspensions |
| 04/09/2013 | US8415299 Methods for improved avian performance |
| 04/09/2013 | US8415298 Administration of FGF2 for treamtent of anxiety |
| 04/09/2013 | US8415297 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/09/2013 | US8415296 Oxyntomodulin peptide analogue |
| 04/09/2013 | US8415295 Heterocyclic boronic acid compounds |
| 04/09/2013 | US8415294 Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth |
| 04/09/2013 | US8415293 Peptide mediators of cholesterol efflux |
| 04/09/2013 | US8415291 Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses |
| 04/09/2013 | US8415290 Self-assembling protein hydrogel with bio-active protein |
| 04/09/2013 | US8415289 Bacterial-derived BLIS for treatment of acne |
| 04/09/2013 | US8415159 Tissue scaffolds derived from forestomach extracellular matrix |
| 04/09/2013 | US8415135 Lactobacillus plantarum and uses thereof |
| 04/09/2013 | US8415125 Method for preparing biological scaffold material |
| 04/09/2013 | US8415113 Diagnostic method for detecting disturbances of the pancreas |
| 04/09/2013 | US8415097 Tumor suppressor gene, p47ING3 |
| 04/09/2013 | US8414914 Compositions for mucosal delivery of agents |
| 04/09/2013 | US8414902 Method for treating depression |
| 04/09/2013 | US8414898 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | US8414887 Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists |
| 04/09/2013 | US8414877 Method for inducing angiogenesis in an infarcted heart by administering a coiled coil chimeric molecule |
| 04/09/2013 | US8414876 Methods of using IL-1 antagonists to treat autoinflammatory disease |
| 04/09/2013 | CA2642537C Vasodilator |
| 04/09/2013 | CA2600628C Combination of egf/ghrp-6 for neurogeneration of central nervous system following autoimmune damage |
| 04/09/2013 | CA2583670C Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions |
| 04/09/2013 | CA2581927C Treatment or prevention of unscheduled bleeding in women on progestogen containing medication |
| 04/09/2013 | CA2546406C Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 04/09/2013 | CA2536436C 2-amido-4-aryloxy-1-carbonyl pyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/09/2013 | CA2446929C Orally administering parathyroid hormone and calcitonin |
| 04/09/2013 | CA2425208C Rna aptamers and methods for identifying the same |
| 04/09/2013 | CA2399219C Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/09/2013 | CA2361658C T helper cell epitopes |
| 04/09/2013 | CA2325341C Mutagenized il13-based chimeric molecules |
| 04/09/2013 | CA2274319C Methods and compositions for polypeptide engineering |
| 04/09/2013 | CA2224176C Gene transfer for treating a connective tissue of a mammalian host |
| 04/04/2013 | WO2013049804A1 Compositions and methods for modulating hemostasis |
| 04/04/2013 | WO2013049731A1 A supplement for ostomy patients |
| 04/04/2013 | WO2013049697A1 Aromatic-cationic peptides and methods for using same |
| 04/04/2013 | WO2013049519A2 Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols |
| 04/04/2013 | WO2013049375A2 Methods and compositions for modulating beta cell proliferation |
| 04/04/2013 | WO2013049307A2 Enhanced immune memory development by aptamer targeted mtor inhibition of t cells |
| 04/04/2013 | WO2013049200A1 Methods of treating periodontal inflammation and periodontal bone loss |
| 04/04/2013 | WO2013049149A2 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions |
| 04/04/2013 | WO2013049093A1 Combination therapy for chemoresistant cancers |
| 04/04/2013 | WO2013048402A1 Thrombopoietin receptor ligands for neuroprotection |
| 04/04/2013 | WO2013048330A1 Method for purification of cleaved pro-insulin |
| 04/04/2013 | WO2013048313A1 Improved formulations of recombinant human bile salt-stimulated lipase |
| 04/04/2013 | WO2013048226A1 Immunomodulator metallopeptides (immps) and compositions containing same |
| 04/04/2013 | WO2013048116A2 Erythropoietin-derived peptide and use therefor |
| 04/04/2013 | WO2013047869A1 Pharmaceutical composition containing loxoprofen or salt thereof |
| 04/04/2013 | WO2013047846A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 04/04/2013 | WO2013047795A1 Granular pharmaceutical composition |
| 04/04/2013 | WO2013047509A1 Novel phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition |
| 04/04/2013 | WO2013047263A1 Hemoglobin-containing liposome and method for producing same |
| 04/04/2013 | WO2013047128A1 Peptide and angiotensin-converting enzyme inhibitor |
| 04/04/2013 | WO2013047082A1 Exogenous opioid peptide-degrading enzyme |
| 04/04/2013 | WO2013045885A1 Treatment for mitrochondrial neurogastrointestinal encephalomyopathy (mngie) |
| 04/04/2013 | WO2013045737A1 Immunogenic gluten peptides and uses thereof |
| 04/04/2013 | WO2013045694A1 Compositions and methods for the treatment of degenerative retinal conditions |
| 04/04/2013 | WO2013045665A1 Composition for topical application comprising a fish protein hydrolysate, applicator and use |
| 04/04/2013 | WO2013045600A1 Novel peptide derivatives as antibiotics |
| 04/04/2013 | WO2013045505A1 Biomarkers for raas combination therapy |
| 04/04/2013 | WO2013045460A1 Alisporivr for treatment of hepatis c virus infection |
| 04/04/2013 | WO2013045404A2 Inhibition of the effect of interleukin 1 beta in order to treat endometriosis |
| 04/04/2013 | WO2013045125A1 Immunocytokine combination therapy |